Donald Notman | CFO |
Antony Mattessich | President, CEO & Director |
Daniel Bollag | SVP, Regulatory Affairs & Quality |
Michael Goldstein | Chief Medical Officer |
Blair Cohen | Guggenheim Securities, LLC |
William Maughan | Cowen and Company |
Dane Leone | BTIG, LLC |
Yi Chen | H.C. Wainwright & Co |
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix Q4 and Year-end Earnings Conference Call. [Operator Instructions]. It is now my pleasure to turn the conference over to Mr. Donald Notman, Chief Financial Officer of Ocular Therapeutix.